You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME/CE

American Academy of Pediatrics Updates Guidelines for Vitamin D Intake

  • Authors: News Author: Laurie Barclay, MD
    CME Author: Désirée Lie, MD, MSEd
  • CME/CE Released: 10/14/2008
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 10/14/2009
Start Activity


Target Audience and Goal Statement

This article is intended for primary care clinicians and specialists who care for children and adolescents.

The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.

Upon completion of this activity, participants will be able to:

  1. Describe risk factors for vitamin D deficiency, vitamin D requirements for children, and new recommended intake guidelines.
  2. Describe recommendations for vitamin D supplementation in adolescents.


Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Laurie Barclay, MD

    is a freelance reviewer and writer for Medscape.

    Disclosures

    Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.

Editor(s)

  • Brande Nicole Martin

    is the News CME editor for Medscape Medical News.

    Disclosures

    Disclosure: Brande Nicole Martin has disclosed no relevant financial information.

Nurse Planner

  • Laurie E. Scudder, MS, NP-C

    Nurse Planner, Medscape; Adjunct Assistant Professor, School of Health Sciences, George Washington University, Washington, DC; Curriculum Coordinator, Nurse Practitioner Alternatives, Inc., Ellicott City; Nurse Practitioner, Baltimore City School-Based Health Centers, Baltimore, Maryland

    Disclosures

    Disclosure: Laurie Scudder, MS, NP-C, has disclosed no relevant financial information.

CME Author(s)

  • Désirée Lie, MD, MSEd

    Clinical Professor, Family Medicine, University of California, Orange; Director, Division of Faculty Development, UCI Medical Center, Orange, California

    Disclosures

    Disclosure: Désirée Lie, MD, MSEd, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should only claim credit commensurate with the extent of their participation in the activity. Medscape Medical News has been reviewed and is acceptable for up to 350 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 09/01/08. Term of approval is for 1 year from this date. This activity is approved for 0.25 Prescribed credits. Credit may be claimed for 1 year from the date of this activity.

    Note: Total credit is subject to change based on topic selection and article length.


    AAFP Accreditation Questions

    Contact This Provider

    For Nurses

  • Medscape is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. Medscape encourages you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 5 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

This activity is not sanctioned by, nor a part of, the American Academy of Pediatrics. Conference news does not receive grant support and is produced independently.

This activity is not sanctioned by, nor a part of, the American Academy of Pediatrics. Conference news does not receive grant support and is produced independently.

CME/CE

American Academy of Pediatrics Updates Guidelines for Vitamin D Intake

Authors: News Author: Laurie Barclay, MD CME Author: Désirée Lie, MD, MSEdFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME/CE Released: 10/14/2008

Valid for credit through: 10/14/2009

processing....

October 14, 2008 — The American Academy of Pediatrics (AAP) has issued updated guidelines for vitamin D intake in infants, children, and teens to prevent rickets and vitamin D deficiency. The new recommendations were posted in the October 13 Early Release issue and will be published in the November 5 print issue of Pediatrics.

The recommendations were also presented at the American Academy of Pediatrics 2008 National Conference and Exhibition in Boston, Massachusetts.

The updated guidelines replace a 2003 AAP clinical report, which recommended a daily intake of 200 IU per day of vitamin D for all infants, from the first 2 months after birth, as well as for children and adolescents. The new recommendations call for a daily intake of 400 IU per day of vitamin D for all infants, children, and adolescents beginning in the first few days of life.

"Rickets attributable to vitamin D deficiency is known to be a condition that is preventable with adequate nutritional intake of vitamin D," write Carol L. Wagner, MD, Frank R. Greer, MD, and the AAP Section on Breastfeeding and Committee on Nutrition. "Despite this knowledge, cases of rickets in infants attributable to inadequate vitamin D intake and decreased exposure to sunlight continue to be reported in the United States and other Western countries, particularly with exclusively breastfed infants and infants with darker skin pigmentation. Rickets, however, is not limited to infancy and early childhood, as evidenced by cases of rickets caused by nutritional vitamin D deficiency being reported in adolescents."

The primary natural source of vitamin D is from skin synthesis from cholesterol after exposure to UVB light. Natural dietary sources of vitamin D are limited, and the amount of sunshine exposure sufficient for the cutaneous synthesis of vitamin D is not easily determined for a given individual. Furthermore, that amount of sunshine exposure may increase the risk for skin cancer. Therefore, the AAP has revised its 2003 recommendations to ensure adequate vitamin D status to include all infants, including those who are exclusively breast-fed, as well as older children and adolescents.

All infants and children, including adolescents, should have a minimal daily intake of 400 IU of vitamin D beginning soon after birth, according to these revised guidelines. The current recommendation for healthy infants, children, and adolescents is based on findings from new clinical trials as well as on the historical precedent of safely administering 400 IU of vitamin D per day in the pediatric and adolescent populations. Furthermore, ingestion of 400 IU of vitamin D daily appears to treat as well as to prevent rickets.

New data suggest that vitamin D has a potential role in maintaining innate immunity and in reducing the risk for certain chronic diseases including diabetes and cancer. This new evidence may eventually change the definition of vitamin D sufficiency or deficiency. Currently, vitamin D insufficiency in adults is defined as a level of 25-hydroxyvitamin D of 50 to 80 nmol/L and vitamin D deficiency as a level less than 50 nmol/L.

Specific recommendations to ensure that healthy infants, children, and adolescents meet the required vitamin D intake of at least 400 IU per day are as follows:

1. Beginning in the first few days of life, breast-fed and partially breast-fed infants should be supplemented with 400 IU per day of vitamin D, and this should be continued unless the infant is weaned to at least 1 L per day or 1 quart per day of vitamin D–fortified formula or whole milk. Vitamin D levels in breast milk range from less than 25 to 78 IU/L, putting exclusively breast-fed infants at greater risk for vitamin D deficiency.

Whole milk should not be given until the infant is at least 1 year old. Use of reduced-fat milk between ages 12 months and 2 years is appropriate in those children for whom overweight or obesity is a concern or for those with a family history of obesity, dyslipidemia, or cardiovascular disease.

2. A vitamin D supplement of 400 IU per day is indicated for all non–breast-fed infants and for older children who are consuming less than 1000 mL per day of vitamin D–fortified formula or milk. The daily intake of each child may include other dietary sources of vitamin D, such as fortified foods.

3. A vitamin D supplement of 400 IU per day is indicated for adolescents who do not ingest 400 IU of vitamin D per day from vitamin D–fortified milk (100 IU per 8-oz serving) and vitamin D–fortified foods (such as fortified cereals and egg yolks).

4. Serum concentrations of 25-hydroxyvitamin D in infants and children should be at least 50 nmol/L (20 ng/mL), based on the available evidence.

5. Despite ingesting 400 IU per day, children at increased risk for vitamin D deficiency, such as those with chronic fat malabsorption and those chronically treated with antiepileptic drugs, may continue to be vitamin D deficient. Children with dark skin pigmentation require 5 to 10 times longer to generate vitamin D3 from sunlight exposure.

Children in these groups may require higher doses of vitamin D supplementation to achieve normal vitamin D status, which should be evaluated with laboratory tests for concentrations of serum 25-hydroxyvitamin D and parathyroid hormone and measures of bone mineral status. When a vitamin D supplement is prescribed, 25-hydroxyvitamin D levels should be monitored every 3 months, and parathyroid hormone and bone mineral status should be monitored every 6 months, until levels normalize.

6. Pediatricians and other healthcare professionals should ensure that vitamin D supplements are readily available to all children in their community, especially to those who are at greatest risk.

Pregnant and lactating women who are vitamin D deficient may expose their offspring to a higher risk for vitamin D deficiency after birth and during lactation, and their vitamin D status should therefore be monitored. Although insufficient vitamin D intake in pregnant women adversely affects fetal skeletal development, tooth enamel formation, and general fetal growth, universal recommendations for high-dose vitamin D supplementation during pregnancy are not currently available.

"Along with adequate vitamin D intake, calcium intake to achieve optimal bone formation and modeling must be ensured," the guidelines authors conclude. "A dietary history is essential in assessing the adequacy of dietary intake for various vitamins, minerals, and nutrients, including vitamin D and calcium. Children and adolescents at increased risk of developing rickets and vitamin D deficiency, including those with increased skin pigmentation, decreased sunlight exposure, chronic diseases characterized by fat malabsorption (cystic fibrosis, etc), and those who require anticonvulsant medications (which induce cytochrome P450 and other enzymes that may lead to catabolism of vitamin D) may require even higher doses than 400 IU/day of vitamin D."

As with other AAP clinical reports, these guidelines automatically expire in 5 years unless reaffirmed, revised, or retired at or before that time. The recommendations in these guidelines are intended to prescribe an exclusive course of treatment or to serve as a standard of medical care. Variations in management considering individual patient circumstances may be appropriate.

Pediatrics. Published online October 13, 2008. 2008;122:1142-1152.

Clinical Context

Rickets and vitamin D deficiency are preventable conditions with adequate nutritional intake of vitamin D but are still prevalent in the United States and other Western countries, particularly in exclusively breast-fed infants and in those with chronic diseases. Rickets has a peak incidence of ages 3 to 18 months and may present with hypocalcemic seizures.

This is an update of the 2003 AAP guidelines for vitamin D intake in children and adolescents, which recommended a daily intake of 200 IU of vitamin D daily beginning at 2 months of life, to account for evidence showing that a higher intake is necessary to avoid vitamin D deficiency and insufficiency.

Study Highlights

  • There is evidence that 400 IU of vitamin D daily not only prevents rickets but also treats the condition.
  • In adults, vitamin D deficiency is defined as a level of 25-hydroxyvitamin D less than 50 nmol/L and vitamin D insufficiency as a level of 50 to 80 nmol/L.
  • The main source of vitamin D is via skin synthesis from cholesterol after exposure to UVB light.
  • Those most susceptible to vitamin D insufficiency include breast-fed infants, those with low sunlight exposure, those with dark skin pigmentation that takes 5 to 10 times longer to generate vitamin D3, and those with chronic diseases such as cystic fibrosis and fat malabsorption.
  • Mothers who are vitamin D deficient may expose their fetuses and infants to higher risk for vitamin D deficiency after birth and during lactation, and their vitamin D status should be monitored.
  • Inadequate vitamin D status in pregnant women has an effect on fetal skeletal development, tooth enamel formation, and general fetal growth.
  • However, universal recommendations for high-dose vitamin D supplementation during pregnancy are not available at present, and recommendations for supplementation in children are thus necessary.
  • Vitamin D levels in breast milk vary from less than 25 IU/L to 78 IU/L, and infants who are exclusively breast-fed are at increased risk for deficiency.
  • Vitamin D supplementation should begin at birth or in the first few days of life with 400 IU per day for breast-fed and partially breast-fed infants.
  • Supplementation should be continued unless the infant is weaned to 1 L per day or 1 quart per day of vitamin D–fortified formula or whole milk.
  • Whole milk should not be used until after age 12 months, and reduced-fat milk is recommended for those with obesity.
  • All non–breast-fed infants and older children ingesting less than 1 L per day of vitamin D–fortified milk or formula should receive 400 IU of vitamin D daily.
  • Adolescents are at increased risk for vitamin D deficiency because the intake of milk was reduced by 36% between the 1970s and the 1990s.
  • Adolescents should be encouraged to drink milk daily (100 IU per 8-oz serving) and to consume vitamin D–fortified foods (cereals and eggs).
  • 1 L of vitamin D–fortified milk daily is required to meet the daily vitamin D recommendations for adolescents.
  • Without adequate dietary intake, adolescents should be supplemented with 400 IU of vitamin D daily.
  • According to available evidence, serum levels of 25-hydroxyvitamin D in infants and adolescents should be 50 nmol/L or higher.
  • In children with additional risk factors for vitamin D deficiency, such as those with chronic diseases, those receiving seizure medications, or those with fat malabsorption, higher doses of vitamin D may be needed daily.
  • In these children, levels of 25-hydroxyvitamin D should be monitored every 3 months until normal levels have been achieved with vitamin D supplementation.
  • Pediatricians and other healthcare professionals should make vitamin D supplements readily available to children in their community, especially those at risk for deficiency or insufficiency.

Pearls for Practice

  • Vitamin D supplementation at 400 IU per day should begin within the first few days of life and is especially recommended in breast-fed children, and supplementation may be higher for children with additional risk factors.
  • Adolescents who do not consume adequate vitamin D in their diet should have an intake of 400 IU of vitamin D supplements daily.

CME/CE Test

  • Print